Search Results 1511-1520 of 20951 for infant development

1. Doxorubicin (intravenous route) - Side effects & uses - Mayo Clinic

   Doxorubicin belongs to the group of medicines known as antineoplastics. It seems to interfere with the growth of cancer cells, which are then eventually ...

2. Mayo Clinic Children's Center: A pediatric center of excellence for complex care

   When a child presents to the Pediatric Diagnostic and Referral Clinic, a coordinated medical team is mobilized around patient and family. Before the patient ...

3. Inguinal hernia - Symptoms & causes - Mayo Clinic

   Mayo Clinic School of Continuous Professional Development. Giving to Mayo ... Sometimes the hernia will be seen only when a baby is crying, coughing or straining ...

4. Dextroamphetamine (oral route) - Side effects & dosage - Mayo Clinic

   This medicine may cause slow growth and weight loss in children. If your child is using this medicine, the doctor will need to keep track of your child's height ...

5. Tropicamide (ophthalmic route) - Side effects & uses - Mayo Clinic

   Mayo Clinic School of Continuous Professional Development ... There are no adequate studies in women for determining infant risk when using this medication during ...

6. Vemurafenib (oral route) - Side effects & dosage - Mayo Clinic

   Mayo Clinic School of Continuous Professional Development ... There are no adequate studies in women for determining infant risk when using this medication during ...

7. Cefadroxil (oral route) - Side effects & dosage - Mayo Clinic

   Mayo Clinic School of Continuous Professional Development ... Studies in women suggest that this medication poses minimal risk to the infant when used during ...

8. Imatinib (oral route) - Side effects & dosage - Mayo Clinic

   This medicine may cause slowed growth and development in children. Your child's doctor may want to monitor their weight and growth regularly. Talk to your ...

9. Trauma in pregnancy: A unique challenge - Mayo Clinic

   Mayo Clinic School of Continuous Professional Development. Giving to Mayo ... growth restriction later in pregnancy. "Overall, the risks versus benefits ...

10. Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD) - Mayo Clinic

    Preclinical experimental drug studies in mouse models of MASLD have shown success in attenuating liver inflammation and the development of liver fibrosis ...